Skip Klein
Managing Director @ Gauss Capital Advisors
Stevenson, United States
Skip Klein is a startup investor at Gauss Capital Advisors in Stevenson. Mr. Klein is currently Managing Director of Gauss Capital Advisors, LLC, a financial consulting and investment advisory firm focused on biopharmaceuticals, which he founded in March 1998. Mr. Klein currently serves on the board of directors of the public biotechnology company Isis Pharmaceuticals, Inc. as well as the Board of Directors of theProspector Funds, Inc., an SEC registered investment company that manages two no-load mutual funds. He has previously served on the boards and Audit Committees of BioMarin Pharmaceutical, Inc.; Clinical Data, Inc.; Genaissance Pharmaceuticals, Inc.; Guilford Pharmaceuticals, Inc.; NPS Pharmaceuticals, Inc.; OSI Pharmaceuticals, Inc.; PDL BioPharma, Inc.; Savient Pharmaceuticals, Inc.; and Synbiotics, Inc. Mr. Klein also serves on the boards of private and non-profit entities. From 1989 to 1998, Mr. Klein was a health care investment analyst at T. Rowe Price Associates, Inc., where he was the founding portfolio manager of the T. Rowe Price Health Sciences Fund, Inc. He has previously served as a Venture Partner of Red Abbey Venture Partners, L.P. and of MPM Capital. Mr. Klein received a B.A., summa cum laude, in Economics from Yale University, and an MBA from the Graduate School of Business at Stanford University.
Last updated:
For AI agents: llms.txt
About Gauss Capital Advisors
Gauss Capital Advisors is a financial and investment advisory firm based in United States.
Gauss Capital Advisors Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Skip Klein
Managing Director
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
